BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 18184809)

  • 1. Activation of the hypoxia-inducible factor-1alpha pathway accelerates bone regeneration.
    Wan C; Gilbert SR; Wang Y; Cao X; Shen X; Ramaswamy G; Jacobsen KA; Alaql ZS; Eberhardt AW; Gerstenfeld LC; Einhorn TA; Deng L; Clemens TL
    Proc Natl Acad Sci U S A; 2008 Jan; 105(2):686-91. PubMed ID: 18184809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATF4 promotes bone angiogenesis by increasing VEGF expression and release in the bone environment.
    Zhu K; Jiao H; Li S; Cao H; Galson DL; Zhao Z; Zhao X; Lai Y; Fan J; Im HJ; Chen D; Xiao G
    J Bone Miner Res; 2013 Sep; 28(9):1870-1884. PubMed ID: 23649506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Regulation of hypoxia inducible factor-1alpha on osteoblast function in osteogenesis].
    Liu XD; Deng LF; Wang J; Qi J; Zhou Q; Wang JS; Wei L; Zhu YP
    Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(47):3357-61. PubMed ID: 18478952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salidroside improves angiogenesis-osteogenesis coupling by regulating the HIF-1α/VEGF signalling pathway in the bone environment.
    Guo Q; Yang J; Chen Y; Jin X; Li Z; Wen X; Xia Q; Wang Y
    Eur J Pharmacol; 2020 Oct; 884():173394. PubMed ID: 32730833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inositol Polyphosphate Multikinase Inhibits Angiogenesis via Inositol Pentakisphosphate-Induced HIF-1α Degradation.
    Fu C; Tyagi R; Chin AC; Rojas T; Li RJ; Guha P; Bernstein IA; Rao F; Xu R; Cha JY; Xu J; Snowman AM; Semenza GL; Snyder SH
    Circ Res; 2018 Feb; 122(3):457-472. PubMed ID: 29279301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolyl hydroxylase inhibitors protect from the bone loss in ovariectomy rats by increasing bone vascularity.
    Liu X; Tu Y; Zhang L; Qi J; Ma T; Deng L
    Cell Biochem Biophys; 2014 May; 69(1):141-9. PubMed ID: 24242187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minocycline accelerates hypoxia-inducible factor-1 alpha degradation and inhibits hypoxia-induced neovasculogenesis through prolyl hydroxylase, von Hippel-Lindau-dependent pathway.
    Li CH; Liao PL; Yang YT; Huang SH; Lin CH; Cheng YW; Kang JJ
    Arch Toxicol; 2014 Mar; 88(3):659-71. PubMed ID: 24292262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development.
    Wang Y; Wan C; Deng L; Liu X; Cao X; Gilbert SR; Bouxsein ML; Faugere MC; Guldberg RE; Gerstenfeld LC; Haase VH; Johnson RS; Schipani E; Clemens TL
    J Clin Invest; 2007 Jun; 117(6):1616-26. PubMed ID: 17549257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway.
    Carroll VA; Ashcroft M
    Cancer Res; 2006 Jun; 66(12):6264-70. PubMed ID: 16778202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Runx2 protein stabilizes hypoxia-inducible factor-1α through competition with von Hippel-Lindau protein (pVHL) and stimulates angiogenesis in growth plate hypertrophic chondrocytes.
    Lee SH; Che X; Jeong JH; Choi JY; Lee YJ; Lee YH; Bae SC; Lee YM
    J Biol Chem; 2012 Apr; 287(18):14760-71. PubMed ID: 22351759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. von Hippel Lindau tumor suppressor and HIF-1alpha: new targets of NSAIDs inhibition of hypoxia-induced angiogenesis.
    Jones MK; Szabó IL; Kawanaka H; Husain SS; Tarnawski AS
    FASEB J; 2002 Feb; 16(2):264-6. PubMed ID: 11772947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxygen sensing and osteogenesis.
    Wang Y; Wan C; Gilbert SR; Clemens TL
    Ann N Y Acad Sci; 2007 Nov; 1117():1-11. PubMed ID: 18056033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dimethyloxalylglycine prevents bone loss in ovariectomized C57BL/6J mice through enhanced angiogenesis and osteogenesis.
    Peng J; Lai ZG; Fang ZL; Xing S; Hui K; Hao C; Jin Q; Qi Z; Shen WJ; Dong QN; Bing ZH; Fu DL
    PLoS One; 2014; 9(11):e112744. PubMed ID: 25394221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of bone regeneration with the accordion technique via HIF-1α/VEGF activation in a rat distraction osteogenesis model.
    Xu J; Sun Y; Wu T; Liu Y; Shi L; Zhang J; Kang Q; Chai Y; Li G
    J Tissue Eng Regen Med; 2018 Feb; 12(2):e1268-e1276. PubMed ID: 28763580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoblast-specific transcription factor Osterix (Osx) and HIF-1α cooperatively regulate gene expression of vascular endothelial growth factor (VEGF).
    Chen D; Tian W; Li Y; Tang W; Zhang C
    Biochem Biophys Res Commun; 2012 Jul; 424(1):176-81. PubMed ID: 22750006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
    Blancher C; Moore JW; Robertson N; Harris AL
    Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-purity magnesium pin enhances bone consolidation in distraction osteogenesis model through activation of the VHL/HIF-1α/VEGF signaling.
    Hamushan M; Cai W; Zhang Y; Lou T; Zhang S; Zhang X; Cheng P; Zhao C; Han P
    J Biomater Appl; 2020 Aug; 35(2):224-236. PubMed ID: 32460592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
    Chen MC; Lee CF; Huang WH; Chou TC
    Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
    Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
    Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression of solid tumors by engineered overexpression of von Hippel-Lindau tumor suppressor protein and antisense hypoxia-inducible factor-1alpha.
    Sun X; Kanwar JR; Leung E; Vale M; Krissansen GW
    Gene Ther; 2003 Dec; 10(25):2081-9. PubMed ID: 14595381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.